Persius/hicric huggingface dataset:
Appeal type: unknown
Decision: unknown

The rules say that plans must pay for a medical service or item if regular Medicare would pay for it in this case.
You can find this rule at 42 Code of Federal Regulations (CFR) Section 422.101.
The rules say that Medicare may cover a drug or biological if it is safe and effective and otherwise reasonable
and necessary. You can find this rule in the Medicare Benefit Policy Manual, Chapter 15, Section 50.4.1.
Medicare rules also allow the plan to use step therapy. This is the process of beginning drug therapy for a
medical condition with "preferred" (or more cost-effective) on-formulary drug alternative(s) and progressing to
other drug therapies only as necessary. A plan must grant an exception to its step therapy rules if it determines
that the requested drug is medically necessary, consistent with the prescriber's statement. The statement must
show that the step therapy drugs: have been ineffective in treating the enrollee; or are likely to be ineffective or
adversely affect the drug's effectiveness or patient compliance; or are likely to cause an adverse reaction or
other harm to the enrollee.
Medicare Advantage plans should ensure that new step therapy requirements do not disrupt ongoing Part B
drug therapies for enrollees. Step therapy may only be applied to new prescriptions or administrations of Part B
drugs for enrollees that are not actively receiving the affected medication. You can find this information at 42
CFR Section 423.578(b)(5)(ii).
If you want to read these Medicare rules, you can go to this website www.medicareappeal.com.
The Plan contract says that the Plan covers items and services in accordance with Medicare rules. The contract
says that the Plan has step therapy requirements for certain Medicare Part B covered drugs/biologicals. The
health plan contract says that Prolia is subject to step therapy. The use of this drug requires that the patient
doesn't have uncorrected pre-existing hypocalcemia. If you meet the clinical criteria, you must also meet these
step therapy requirements: has tried or cannot use zoledronic acid. You can find this rule in the plan's step
therapy policy.
Appeal type: unknown
Decision: unknown

The rules say that plans must pay for a medical service or item if regular Medicare would pay for it in this case. You can find this rule at42 Code of Federal Regulations (CFR) Section 422.101.The rules say that Medicare pays for care in a skilled nursing facility (SNF) when all of the following four factors are met:1. The patient requires skilled nursingor skilled rehabilitation services;2. The patient requires these services on a daily basis;3. As a practical matter, the daily skilled services can be provided only on an inpatient basis in a SNF; and4. The services are reasonable and necessary for thetreatment of the patient's illness or injury or the services must be needed to establish a safe and effective maintenance program or to prevent the patient's condition from getting worse. You can find these rules at 42 CFR Section 409.31 and in the Medicare Benefit Policy Manual, Chapter 8, Section 30.  The rules say that custodial care is not covered. Custodial care is personal care for a person who does not need ongoing care from trained medical or paramedical staff. Custodial care serves to help with the activities of daily living. This means the care includes help in walking, getting in and out of bed, bathing, dressing, feeding, and using the toilet. Fixing meals and taking charge of medicine that usually can be self-administered are also custodialcare services. You can find this rule in the Medicare Benefit Policy Manual, Chapter 16, Section 110.If you want to read these Medicare rules, you can go to this website www.medicareappeal.com.The Plan contract says that the Plancovers items and services in accordance with Medicare rules.
Appeal type: unknown
Decision: unknown

The rules say that plans must pay for a medical service or item if regular Medicare would pay for it in this case.
You can find this rule at 42 Code of Federal Regulations (CFR) Section 422.101.

The rules say that molecular pathology procedures (Tier1 and Tier 2) may be eligible for coverage when ALL
of the following criteria are met:
1. Alternative laboratory or clinical tests to definitively diagnose the disorder/identify the condition are
unavailable or results are clearly equivocal; AND
2. Availability of a clinically valid test based on published peer reviewed medical literature; AND
3. Testing assay(s) are Food and Drug Administration (FDA) approved/cleared or if LDT (lab developed test)
or LDT protocol or FDA modified test(s) the laboratory documentation should support assay(s) of analytical
validity and clinical utility; AND
4. Results of the testing must directly impact treatment or management of the Medicare beneficiary; AND
5. For testing panels, including but not limited to, multiple genes or multiple conditions, and in cases where a
tiered approach/method is clinically available, testing would be covered ONLY for the number of genes or test
that are reasonable and necessary to obtain necessary information for therapeutic decision making; AND
6. Individual has not previously received genetic testing for the disease/condition. (In general, diagnostic
genetic testing for a disease should be performed once in a lifetime.) Exceptions include clinical scenarios
whereby repeat testing of somatically-acquired mutations (for example, pre- and post- therapy) may be required
to inform appropriate therapeutic decision-making.

You can find this rule in Local Coverage Determination (LCD): Molecular Pathology Procedures (L35000) -
Effective July 1, 2020.

If you want to read these Medicare rules, you can go to this website www.medicareappeal.com.

The Plan contract says that the Plan covers items and services in accordance with Medicare rules.
Appeal type: unknown
Decision: unknown

The rules say that plans must pay for a medical service or item if regular Medicare would pay for it in this case. You can find this rule at 42 Code of Federal Regulations (CFR) Section 422.101.

The rules say that a Medicare plan may restrict members to a network of providers as long as medically necessary covered care is accessible and available through this network. The rules say that the Plan must arrange for specialty care outside of the Plan provider network when network providers are unavailable or inadequate to meet a member's medical needs. You can find this rule at 42 CFR Section 422.112(a)(3).

If you want to read these Medicare rules, you can go to this website www.medicareappeal.com.

The Plan contract says that the Plan covers items and services in accordance with Medicare rules. The Plan contract says that, with limited exceptions, members of the Plan must use network providers to get medical care and services. The only exceptions are emergencies, urgently needed care when the network is not available (generally, when the enrollee is out of the area), out-of-area dialysis services, and cases in which the Plan authorizes the use of out-of-network providers. You can find this information on page 11 of the 2020 Evidence of Coverage.
Appeal type: unknown
Decision: unknown

The rules say that plans must pay for a medical service or item if regular Medicare would pay for it in this case.
You can find this rule at 42 Code of Federal Regulations (CFR) Section 422.101.

The rules say that effective for claims with dates of service on and after March 3, 2009, the Centers for
Medicare & Medicaid Services finds that the evidence is sufficient to determine that the results of the sleep
tests identified below can be used by a beneficiary's treating physician to diagnose obstructive sleep apnea
(OSA), that the use of such sleep testing technologies demonstrates improved health outcomes in Medicare
beneficiaries who have OSA and receive the appropriate treatment, and that these tests are thus reasonable and
necessary under section 1862(a)(1)(A) of the Social Security Act.
1. Type I PSG is covered when used to aid the diagnosis of OSA in beneficiaries who have clinical signs and
symptoms indicative of OSA if performed attended in a sleep lab facility.
2. Type II or Type III sleep testing devices are covered when used to aid the diagnosis of OSA in beneficiaries
who have clinical signs and symptoms indicative of OSA if performed unattended in or out of a sleep lab
facility or attended in a sleep lab facility.
3. Type IV sleep testing devices measuring three or more channels, one of which is airflow, are covered when
used to aid the diagnosis of OSA in beneficiaries who have signs and symptoms indicative of OSA if
performed unattended in or out of a sleep lab facility or attended in a sleep lab facility.
4. Sleep testing devices measuring three or more channels that include actigraphy, oximetry, and peripheral
arterial tone, are covered when used to aid the diagnosis of OSA in beneficiaries who have signs and symptoms
indicative of OSA if performed unattended in or out of a sleep lab facility or attended in a sleep lab facility.
You can find this rule in National Coverage Determination (NCD) for Sleep Testing for Obstructive Sleep
Apnea (OSA) (240.4.1) - Effective March 3, 2009.

If you want to read these Medicare rules, you can go to this website www.medicareappeal.com.

The Plan contract says that the Plan covers items and services in accordance with Medicare rules.
Appeal type: unknown
Decision: unknown

The rules say that plans must pay for a medical service or item if regular Medicare would pay for it in this case. 
You can find this rule at 42 Code of Federal Regulations (CFR) Section 422.101. 
 
Indications: 
61623; Patient must have history of at least 3 months of moderate to severe pain with functional impairment 
and pain is inadequately responsive to conservative care such as NSAIDs, acetaminophen, physical 
therapy (as tolerated). 
61623; Pain is predominantly axial and, with the possible exception of facet joint cysts, not associated with 
radiculopathy or neurogenic claudication. 
61623; There is no non-facet pathology that could explain the source of the patient?s pain, such as fracture, 
tumor, infection, or significant deformity. 
61623; Clinical assessment implicates the facet joint as the putative source of pain. 
You can find more information in the Local Coverage Determination (LCD) Facet Joint Injections, Medial 
Branch Blocks, and Facet Joint Radiofrequency Neurotomy (L35936). 
 
The rules say that medically necessary services are those that are reasonable and necessary for the diagnosis or 
treatment of an illness or injury. Medically necessary services include services to improve the functioning of a 
malformed body member. You can find this rule in the Social Security Act, Section 1862(a)(1)(A). 
 
The rules say that services that are not medically necessary are not covered. The rules also say that 
experimental and investigational devices are not covered. You can find this rule at 42 CFR Sections 411.15 and 
411.15(o). 
 
If you want to read these Medicare rules, you can go to this website www.medicareappeal.com. 
 
The Plan contract says that the Plan covers items and services in accordance with Medicare rules.
Appeal type: unknown
Decision: unknown

The rules say that plans must pay for a medical service or item if regular Medicare would pay for it in this case. 
You can find this rule at 42 Code of Federal Regulations (CFR) Section 422.101. 
 
The rules say that Medicare will not pay for dental services. Dental services are items and services involving 
the care, treatment, filling, removal or replacement of teeth or structures directly supporting the teeth. Medicare 
defines "structures directly supporting the teeth" as the periodontium, which includes the gingivae, 
dentogingival junction, periodontal membrane, cementum of the teeth, and alveolar process. You can find this 
rule in the SSA, Section 1862(a)(12) and Medicare Benefit Policy Manual, Chapter 15, Section 150. 
 
If you want to read these Medicare rules, you can go to this website www.medicareappeal.com. 
 
The Plan contract says that the Plan covers items and services in accordance with Medicare rules. The contract 
says that the Plan covers certain dental services as a supplemental (extra) benefit. The health plan contract says 
that D2751 has a benefit limitation of one per tooth every sixty months. You can find this information in the 
plan's Preventive & Comprehensive Dental Coverage Customer Handbook, January 2021.
Appeal type: unknown
Decision: unknown

The rules say that plans must pay for a medical service or item if regular Medicare would pay for it in this case. 
You can find this rule at 42 Code of Federal Regulations (CFR) Section 422.101. 
The rules say that Medicare will pay for an IRF admission when the services are reasonable and medically 
necessary. The patient must require an intensive and coordinated interdisciplinary approach to providing 
rehabilitation. The patient must need active and ongoing treatment by more than one therapy discipline. One of 
the therapies must be physical therapy or occupational therapy. The patient must need and be expected to 
actively participate in and to benefit from an intensive rehabilitation therapy program. This intensive 
rehabilitation therapy program generally consists of at least three hours of therapy per day at least five days per 
week. The patient does not need to be expected to achieve complete independence in self-care nor be expected 
to return to his or her prior level of functioning. The patient must need supervision by a rehabilitation 
physician. The physician must see the patient at least three days per week throughout the stay. You can find 
these rules in the Medicare Benefit Policy Manual, Chapter 1, Sections 110.2 and 110.2.5 and at 42 CFR 
Section 412.622. 
If you want to read these Medicare rules, you can go to this website www.medicareappeal.com.
Appeal type: unknown
Decision: unknown

The rules say that plans must pay for a medical service or item if regular Medicare would pay for it in this case. 
You can find this rule at 42 Code of Federal Regulations (CFR) Section 422.101. 
 
The rules state that viscosupplementation therapy for the knee via intra-articular injections of hyaluronic 
preparations will be considered medically reasonable and necessary when ALL of the following conditions are 
met: 
61623; The patient is symptomatic. Such symptoms may include pain which interferes with the activities of 
daily living such as ambulation and prolonged standing, or pain interrupting sleep, crepitus, and/or 
knee stiffness  
61623; The clinical diagnosis is supported by radiologic evidence of osteoarthritis of the knee such as joint 
space narrowing, subchondral sclerosis, osteophytes and sub-chondral cysts 
61623; If appropriate, other diagnoses have been excluded by appropriate evaluation and management 
services, laboratory and imaging studies (i.e. the pain and functional disability is not considered 
likely to be due to a diagnosis other than osteoarthritis of the knee.) 
61623; The patient has failed at least three months of conservative therapy. Conservative therapy is defined 
as: 
o Nonpharmacologic therapy (such as but not limited to home exercise program, education, 
weight loss, physical therapy if indicated); and 
o If not contraindicated, simple analgesics and NSAIDS. 
o The patient has failed to respond to aspiration of the knee and intra-articular corticosteroid 
injection therapy when inflammation is a significant component of the patient?s symptoms 
and intra-articular corticosteroids are not contraindicated. 
 
You can find these rules in Local Coverage Determination (LCD) Viscosupplementation Therapy for Knee 
(L33767). 
 
If you want to read these Medicare rules, you can go to this website www.medicareappeal.com. 
 
The Plan contract says that the Plan covers items and services in accordance with Medicare rules.
Appeal type: unknown
Decision: unknown

The rules say that plans must pay for a medical service or item if regular Medicare would pay for it in this case. 
You can find this rule at 42 Code of Federal Regulations (CFR) Section 422.101. 
 
The rules state that custodial care is not covered. Custodial care is personal care for a person who does not need 
ongoing care from trained medical or paramedical staff. Custodial care serves to help with the activities of 
daily living. This means the care includes help in walking, getting in and out of bed, bathing, dressing, feeding, 
and using the toilet. Fixing meals and taking charge of medicine that usually can be self-administered are also 
custodial care services. You can find this rule in the Medicare Benefit Policy Manual, Chapter 16, Section 110. 
 
If you want to read these Medicare rules, you can go to this website www.medicareappeal.com. 
 
The Plan contract says that the Plan covers items and services in accordance with Medicare rules.
Appeal type: unknown
Decision: unknown

The rules say that plans must pay for a medical service or item if regular Medicare would pay for it in this case. 
You can find this rule at 42 Code of Federal Regulations (CFR) Section 422.101. 
 
The rules say that Medicare may cover medically accepted off-label uses for FDA-approved drugs used in an 
anti-cancer chemotherapeutic regimen. Medicare maintains a list of compendia which define if a use is 
medically accepted. The off-label use must be supported in one or more of these compendia or in published, 
peer-reviewed medical literature. An off-label use must be supported in one or more of the compendia and the 
use must not be listed as unsupported, not indicated, not recommended, or equivalent terms, in any of the 
compendia. An off-label use may also be determined by the carrier in the state to be reasonable and necessary. 
You can find these rules and the list of the Medicare-recognized compendia in the Medicare Benefit Policy 
Manual, Chapter 15, Section 50.4.5. 
 
The rules say that Indications and Limitations of Coverage 
 
B. Nationally Covered Indications 
 
A. Effective for services performed on or after August 7, 2019, the Centers for Medicare & Medicaid Services 
(CMS) covers autologous treatment for cancer with T-cells expressing at least one chimeric antigen receptor 
(CAR) when administered at healthcare facilities enrolled in the FDA risk evaluation and mitigation strategies 
(REMS) and used for a medically accepted indication as defined at Social Security Act section 1861(t)(2) -i.e., 
is used for either an FDA-approved indication (according to the FDA-approved label for that product), or for 
other uses when the product has been FDA-approved and the use is supported in one or more CMS-approved 
compendia. 
 
C. Nationally Non-Covered 
 
Effective for services performed on or after August 7, 2019, the use of non-FDA-approved autologous T-cells 
expressing at least one CAR is non-covered. Autologous treatment for cancer with T-cells expressing at least 
one CAR is non-covered when the requirements in Section A are not met. 
 
D. Other 
 
Effective for services performed on or after August 7, 2019, routine costs in clinical trials that use CAR T-cell 
therapy as an investigational agent that meet the requirements listed in NCD 310.1 will be covered. 
 
You can find this information in Medicare's National Coverage Determination (NCD) for Chimeric Antigen 
Receptor (CAR) T-cell Therapy (110.24). 
 
If you want to read these Medicare rules, you can go to this website www.medicareappeal.com. 
 
The Plan contract says that the Plan covers items and services in accordance with Medicare rules. [e.g. The 
Plan contract also says that acupuncture services are not covered by the Plan. You can find this information on 
page 27 of the Plan's 2010 Evidence of Coverage.]
Appeal type: unknown
Decision: unknown

The rules say that plans must pay for a medical service or item if regular Medicare would pay for it in this case. 
You can find this rule at 42 Code of Federal Regulations (CFR) Section 422.101. 
 
The rules say a health plan must disclose to its enrollees in clear, accurate terms all cost-sharing information 
(such as copayments, deductibles and coinsurance). You can find this rule at 42 CFR Section 422.111(a) and 
(b). 
 
The rules say that a copayment is a fixed amount charged to an enrollee on a per-service basis. The rules say 
that coinsurance is a fixed percentage of the total amount paid for a health care service that can be charged to 
an enrollee on a per-service basis. You can find this rule at 42 CFR Section 422.2. 
 
If you want to read these Medicare rules, you can go to this website www.medicareappeal.com. 
 
The Plan contract says that the Plan covers items and services in accordance with Medicare rules. The Plan 
contract says that maximum out-of-pocket (MOOP) amount for 2020 is $1,000. You can find this information 
in Chapter 4 on page 2 of the Plan's 2020 EOC. 
 
The Plan contract also says that enrollees must pay a $150 copayment for each radiological diagnostic service. 
You can find this information in Chapter 4 on page 31 of the Plan's 2020 EOC.
Appeal type: unknown
Decision: unknown

The rules say that plans must pay for a medical service or item if regular Medicare would pay for it in this case. You can find this rule at 42 Code of Federal Regulations (CFR) Section 422.101.The Appeal Number is:1-9737553866The Appeal Number is:1-9737553866
The rules say that providers must report services correctly. Procedures should be reported with the CPT code that describes the services performed. You can find this rule in the Medicare National Correct Coding Initiative Manual, Chapter I(A).If you want to read these Medicare rules, you can go to this website www.medicareappeal.com.The Plan contract says that the Plan covers items and services in accordance with Medicare rules
Appeal type: unknown
Decision: unknown

The rules say that plans must pay for a medical service or item if regular Medicare would pay for it in this case. 
You can find this rule at 42 Code of Federal Regulations (CFR) Section 422.101. 
 
The rules say that a Medicare plan may restrict members to a network of providers as long as medically 
necessary covered care is accessible and available through this network. The rules say that the Plan must 
arrange for specialty care outside of the Plan provider network when network providers are unavailable or 
inadequate to meet a member's medical needs. You can find this rule at 42 CFR Section 422.112(a)(3). 
 
If you want to read these Medicare rules, you can go to this website www.medicareappeal.com. 
 
The Plan contract says that the Plan covers items and services in accordance with Medicare rules. The Plan 
contract says that, with limited exceptions, members of the Plan must use network providers to get medical care 
and services. The only exceptions are emergencies, urgently needed care when the network is not available 
(generally, when the enrollee is out of the area), out-of-area dialysis services, and cases in which the Plan 
authorizes the use of out-of-network providers. You can find this information in Chapter 3 on pages 32-33 of 
the plan's 2021 Evidence of Coverage.